講演情報
[P-70]IdeS improves vaccination efficacy and gene delivery by reducing pre-existing antibodies
*Yuzy Fauzyah1,2, Paola Miyazato1,2, Kotaro Ishida1,2, Shinya Okamura1,2, Hirotaka Ebina1,2,3,4,5 (1. The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Suita, Osaka, Japan, 2. Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, Suita, Osaka, Japan, 3. Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka, Japan, 4. Center for Advanced Modalities and DDS (CAMaD), The University of Osaka, Suita, Osaka, Japan, 5. Center for Infectious Disease Education and Research (CiDER), The University of Osaka, Suita, Osaka, Japan)